Frequency and distribution of asymptomatic brain lesions in patients with β-thalassemia intermedia

Keywords

Thrombocytosis, Medicine, Splenectomy, Asymptomatic, Gastroenterology

References

• Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia.Edoardo Lozza — 2000
• Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and IranAlì Taher, Hussain Isma’eel, Ghassan Mehio — 2006
• Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy.Russell E. Ware, Sherri A. Zimmerman, Pamela B. Sylvestre — 2004
• The hypercoagulable state in thalassemia.Amiram Eldor, Eliezer A. Rachmilewitz — 2002
• Thalassemia major - on the verge of bleeding or thrombosis?Rahul Naithani, Jagdish Chandra, Shashi Narayan — 2006
• Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermediaAlì Taher, Khaled M. Musallam, Wassim Nasreddine — 2010
• Phosphatidylserine in the outer leaflet of red blood cells from β‐thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodesVered Borenstain‐Ben Yashar, Yechezkel Barenholz, Esther Hy‐Am — 1993
• Genotype–phenotype relationship of patients with β-thalassemia taking hydroxyurea: a 13-year experience in IranMehran Karimi, Sezaneh Haghpanah, Ali Farhadi — 2011
• Hematologic and Clinical Responses of Thalassemia Intermedia Patients to Hydroxyurea During 6 Years of Therapy in IranMehran Karimi, Hadi Darzi, Majid Yavarian — 2005
• Hydroxyurea downregulates endothelin-1 gene expression and upregulates ICAM-1 gene expression in cultured human endothelial cellsMathilde Le Brun, Sandrine Bourdoulous, Pierre Olivier Couraud — 2003
• Protein C and antithrombin III in polytransfused thalassemic patients.Salvatore Musumeci, Salvatore Leonardi, Riccardo Di Dio — 1987
• Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.W. T. Longstreth, Teri A. Manolio, Alice M. Arnold — 1996
• Cerebrovascular accident in beta-thalassemia major (beta-TM) and beta-thalassemia intermedia (beta-TI).Mehran Karimi, Maryam Khanlari, Eliezer A. Rachmilewitz — 2008
• Lessons From the Stroke Prevention Trial in Sickle Cell Anemia (STOP) StudyRobert J. Adams — 2000
• MR imaging of the brain: findings in asymptomatic patients with thalassemia intermedia and sickle cell-thalassemia disease.L. Manfrè, E Giarratano, Aurelio Maggio — 1999
• Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience.Béatrice Gulbis — 2005
• Clinical silent cerebral infarct (SCI) in patients with thalassemia diseases assessed by magnetic resonance imaging (MRI).Pichest Metarugcheep, Somsak Chanyawattiwongs, Kamolrat Srisubat — 2008
• Magnetic resonance imaging to determine the incidence of brain ischaemia in patients with β-thalassaemia intermediaHadi Bagheri, Fatemeh Rastgu, Eliezer A. Rachmilewitz — 2010
• Hydroxyurea Therapy Mobilises Arachidonic Acid from Inner Cell Membrane Aminophospholipids in Patients with Homozygous Sickle Cell DiseaseAhmed Daak, Kebreab Ghebremeskel, Mustafa I. Elbashir — 2011
• Adhesion molecules and hydroxyurea in the pathophysiology of sickle cell diseaseChris A. Johnson, Marilyn J. Telen — 2008

Cited by

• Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and managementRobert C. Andringa — 2016
• The frequency of silent cerebral ischemia in patients with transfusion-dependent β-thalassemia majorMehran Karimi, Foroogh Toosi, Sezaneh Haghpanah — 2015
• Neurological complications of beta-thalassemiaPetros Nemtsas, Marianthi Arnaoutoglou, Vassilios Perifanis — 2015
• Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia PatientsMohammadreza Bordbar, Samir Silavizadeh, Sezaneh Haghpanah — 2014
• Cerebral infarction in β-thalassemia intermedia: breaking the silence.Khaled M. Musallam, Alì Taher, Mehran Karimi — 2012
• Guidelines for Diagnosis and Management of Beta-Thalassemia IntermediaMehran Karimi, Nader Cohan, Vincenzo De Sanctis — 2014
• Evaluation of the Relationship Between Hb F Levels and Nucleated Red Blood Cells with Morbidity in Non Transfusion-Dependent Thalassemia PatientsMehran Karimi, Parisa Jooya, Sezaneh Haghpanah — 2016
• Frequency of silent cerebral ischemia in patients with transfusion-dependent β-thalassemia major compared to healthy individualsMehran Karimi, Sezaneh Haghpanah, Parisa Pishdad — 2016
• Revisiting beta thalassemia intermedia: past, present, and future prospectsN. Ben Salah, Rayan Bou‐Fakhredin, Fethi Mellouli — 2017
• Hypercoagulability and Vascular Disease.Alì Taher, Maria Domenica Cappellini, Rayan Bou‐Fakhredin — 2017
• Neuroimaging Abnormalities in Patients With Nontransfusion-dependent ThalassemiaJaikumar Govindaswamy Ramamoorthy, Amita Trehan, Jasmina Ahluwalia — 2019
• No evidence of increased cerebrovascular involvement in adult neurologically‐asymptomatic β‐Thalassaemia. A multicentre multimodal magnetic resonance studyImmacolata Tartaglione, Camilla Russo, Andrea Elefante — 2019
• Attention, response inhibition and brain event‐related potential alterations in adults with beta‐thalassaemia majorSivan Raz, Ariel Koren, Carina Levin — 2019
• Frequency of silent brain lesions and aspirin protection evaluation over 3 years follow-up in beta thalassemia patientsMehran Karimi, Sezaneh Haghpanah, Parisa Pishdad — 2019
• Thromboembolic Events in Severe Thalassemia SyndromesMozhgan Hashemieh — 2020
• Cerebrovascular Complications of AnemiaAna Catarina Fonseca, Daniela P. Silva, Joana Brioso Infante — 2021
• Vascular Brain Damage in Thalassemia Syndrome: An Emerging ChallengeMozhgan Hashemieh, Narjes Jafari — 2022
• Long-term Results of Splenectomy in Transfusion-dependent ThalassemiaTugberk Akca, Gul N. Ozdemir, Ali Aycicek — 2022
• Imaging of Central Nervous System Involvement in Pediatric Hematologic DisordersSevinç Kalın, Korgün Koral — 2022
• Modified Magnetic Resonance Imaging Burden of Cerebral Small Vessel Disease and Related Risk Factors in Patients With ThalassemiaXiuying Liu, Kunling Yang, Lanfeng Sun — 2023

Related papers

• TROMBOCYTOSIS FOLLOWING SPLENECTOMY IN PEDIATRIC PATIENTSAndreea Dincă, Cristina Oana Mărginean, D Baghiu — 2016
• [Thrombocytosis after splenectomy in children].Alekseev Vs, Platonov Aa, Malov Ag — 2008
• Thrombo-embolism and increased platelet adhesiveness in post-splenectomy thrombocytosis.J. Hirsh, J. A. McBride, J. V. Dacie — 1966
• Thrombocytosis following splenectomy: with or without additional organ resection.Takatsugu Oida, Hisao Kano, Kenji Mimatsu — 2012
• Anaesthetic considerations in a case of post splenectomy reactive thrombocytosisD R Arora, Naveen Arora — 2023
• Persistent Post‐Splenectomy Thrombocytosis and Thrombo‐embolism: A Consequence of Continuing AnaemiaJ. Hirsh, J. V. Dacie — 1966
• Evaluation of platelet function in postsplenectomy thrombocytosis.Randi Ml, F. Fabris, S. Donà — 1987
• Splenectomy is associated with a higher risk for venous thromboembolism: A prospective cohort study.Debora H. Lee, Galinos Barmparas, Nicole Fierro — 2015